Fundraising FoxViewMind Joins Bio-Hermes-002 Landmark Study
1 known investors
Find your way into ViewMind Joins Bio-Hermes-002 Landmark Study
Sign up to see every warm intro you have to ViewMind Joins Bio-Hermes-002 Landmark Study
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ViewMind Joins Bio-Hermes-002 Landmark Study team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The Global Alzheimer's Platform Foundation is a nonprofit organization that reduces the time and cost of clinical trials for Alzheimer's and Parkinson's disease by coordinating multi-site research networks and providing trial management, data, and participant recruitment services. It serves pharmaceutical sponsors, contract research organizations, and clinical research sites seeking to accelerate neurodegenerative disease drug development.
Founders & leadership
JD
John DwyerPresident
Investors · 1
Frequently asked questions
- What does ViewMind Joins Bio-Hermes-002 Landmark Study do?
- The Global Alzheimer's Platform Foundation is a nonprofit organization that reduces the time and cost of clinical trials for Alzheimer's and Parkinson's disease by coordinating multi-site research networks and providing trial management, data, and participant recruitment services. It serves pharmaceutical sponsors, contract research organizations, and clinical research sites seeking to accelerate neurodegenerative disease drug development.
- Who are ViewMind Joins Bio-Hermes-002 Landmark Study's investors?
- ViewMind Joins Bio-Hermes-002 Landmark Study's investors include Wealthing VC Club.